Life Insurance for Heart Disease

Life insurance for heart disease is more accessible than most people expect — and more variable in outcome than any single carrier or online quote tool can show. Heart disease as a diagnostic category covers an enormous range of conditions, severity levels, and stability profiles, and underwriters treat these distinctions with real precision. A person with well-controlled coronary artery disease three years post-stent and a clean stress test is a fundamentally different underwriting case than someone with recent heart failure, reduced ejection fraction, and two hospitalizations in the past 18 months — and the insurance outcome should reflect that difference. At Diversified Insurance Brokers, we work with cardiac applicants every week across the full spectrum of heart disease history, and the consistent finding is this: when the right carrier evaluates a well-prepared application that accurately tells the story of a stable, managed cardiac condition, approvals are far more common and at far better rates than applicants who were told “no” by the wrong company expect.

What drives the outcome in heart disease underwriting is not the diagnosis name — it is the complete picture of what the condition actually is, how long it has been stable, what follow-up testing shows, and whether the risk factors that contribute to cardiac events are controlled. Carriers that specialize in or have experience with cardiac underwriting interpret this picture with nuance. Carriers that do not apply conservative rules based on diagnostic categories alone, producing declines and heavy ratings for applicants who could have been approved with better carrier selection. Working with a broker who can pre-screen your specific cardiac profile across 100+ carriers — rather than submitting a standard application to whoever the online tool happens to suggest — is the single most consequential step in improving your outcome. Our resource on best life insurance for pre-existing conditions covers the broader framework we use for complex medical underwriting.

Can You Get Life Insurance With Heart Disease?

Yes — many people can, and most people with stable heart disease who receive discouraging information from one carrier or one broker have not yet accessed the part of the market that is actually suited for their case. Heart disease is a broad category, and underwriting outcomes vary widely based on the exact condition and how well it is controlled. Two people may both have “heart disease” in their medical records, but their insurance results can be completely different depending on the severity, testing history, and stability timeline. Underwriters are not trying to confirm a diagnosis — they are trying to assess the likelihood of future events, and that assessment is built from the clinical evidence of stability, control, and management rather than from the diagnostic code alone.

When people are told they cannot get life insurance due to heart disease, the reason is most often one of three problems. The first is carrier mismatch: the application was sent to a company whose underwriting guidelines are genuinely strict for that specific cardiac profile, and the result reflects that strictness rather than insurability across the market. The second is timing: the application was submitted too close to a major event, before the stability window many carriers require had been satisfied. The third is documentation: the carrier received incomplete or unclear medical records that did not clearly communicate stability, forcing a conservative default decision. All three problems are addressable with deliberate approach. Our resource on life insurance with pre-existing conditions explains how we approach complex medical underwriting across multiple carriers, and our resource on what will disqualify you from life insurance covers the narrow set of situations where coverage genuinely is not available and why.

Cardiac Conditions and Their Typical Underwriting Outlook

Life insurance underwriting for heart disease varies significantly by condition type, and knowing approximately where your specific diagnosis sits in the underwriting landscape helps set realistic expectations before the application process begins. The table below maps the most common cardiac conditions to their typical underwriting outcomes, the stability factors that most influence the result, and the documentation that carries the most weight in carrier review.

Heart Disease Life Insurance: Condition-by-Condition Underwriting Outlook

This table represents general patterns based on how most major carriers approach these conditions. Individual outcomes depend on the full medical picture — overlapping conditions, risk factor control, age at application, and documentation quality all influence the final result. Our specific resource on life insurance after a heart attack covers the MI underwriting timeline in greater detail, and our resource on life insurance for atrial fibrillation covers that specific rhythm condition’s underwriting profile, including how AF type and anticoagulation status affect outcomes.

What Underwriters Actually Look At for Heart Disease Life Insurance

Heart disease underwriting becomes far less intimidating when you understand what the carrier is actually trying to confirm. Insurance companies are assessing risk: specifically, the likelihood of a future major cardiac event, the likelihood of decline in cardiac function, and whether your overall health profile demonstrates stability and management. Every piece of information in the application feeds into one of these three questions.

Time Since Diagnosis or Last Event

Many carriers define minimum stability windows after major cardiac events — periods during which they generally will not offer coverage or will offer only conservative terms, regardless of how stable the patient appears to be. These windows exist because clinical stability in the immediate aftermath of a major event (an MI, a stent placement, a hospitalization for decompensated heart failure, or a cardiac surgery) does not yet predict long-term stability with enough confidence for underwriters to make a standard risk assessment. After the minimum window passes and follow-up care demonstrates sustained stability, far more options typically become available. For most major events, meaningful improvement in underwriting options tends to occur around the 12-month mark, with further improvement at 24 months and beyond. This timeline is not universal across all carriers — some are more flexible and some more conservative — which is exactly why carrier selection matters at this stage.

Symptoms and Day-to-Day Function

Underwriters focus heavily on whether a cardiac applicant is experiencing ongoing symptoms that suggest active disease progression or inadequate control. Angina (chest pain or discomfort, whether stable or unstable), exertional shortness of breath, fainting or near-fainting episodes, significant exercise intolerance, and repeated emergency room visits all raise underwriting concern because they suggest the cardiac condition is not as controlled as the diagnosis history alone might indicate. A stable symptom profile — particularly good exercise tolerance and absence of daily limiting symptoms — supports better outcomes even when the underlying disease history is significant. Applicants who are living normal active lives with well-managed conditions are underwritten differently from those whose daily function is limited by ongoing cardiac symptoms.

Follow-Up Testing and Results

The most objective evidence an underwriter has about cardiac stability comes from clinical testing, and the recency and quality of that testing matters enormously. Outdated testing — an echocardiogram from four years ago, a stress test from before the most recent intervention — leaves the underwriter without current evidence of stability, which typically results in conservative pricing that does not reflect the applicant’s actual current state. When we help cardiac applicants, we strongly prefer to work with current cardiology notes and testing that clearly documents stability in plain language. The most commonly reviewed tests across cardiac conditions are echocardiograms (which show structural function and ejection fraction), stress tests (which assess functional capacity and ischemic response), angiograms and catheterization reports (which document coronary anatomy and intervention history), Holter monitors and event monitors (which document arrhythmia frequency and type), and BNP or NT-proBNP levels (which indicate the degree of hemodynamic stress in heart failure cases). The specific test that matters most depends on the diagnosis — not every cardiac applicant needs every test, but every cardiac application benefits from having the relevant testing current.

Ejection Fraction

Ejection fraction — the percentage of blood pumped out of the left ventricle with each heartbeat, typically measured by echocardiogram — is one of the most influential single data points in cardiac underwriting across multiple condition categories. Normal ejection fraction (generally 55 percent or above) supports better underwriting outcomes by indicating the heart’s pumping function is intact. Mildly reduced ejection fraction (typically 45 to 54 percent) is reviewed more carefully, with outcomes depending on trend (improving, stable, or declining), symptoms, and the underlying diagnosis. Significantly reduced ejection fraction (below 40 percent, classified as reduced EF heart failure) produces the most conservative underwriting outcomes, though stable cases with good medical management and no recent hospitalizations can still be insurable with the right carrier selection. The ejection fraction number is important, but the trend over serial echocardiograms — whether it is improving with treatment, holding steady, or declining — often matters as much as the absolute number.

Risk Factor Control

Heart disease underwriting does not evaluate the cardiac condition in isolation — it evaluates the whole health context in which the cardiac condition exists. Blood pressure, cholesterol levels, diabetes control (hemoglobin A1C and fasting glucose), tobacco history, body weight, sleep apnea status, and family history all factor into the overall risk assessment. In many cardiac cases, the risk factors contribute as much to the final pricing decision as the cardiac history itself, which means meaningful improvement in risk factor control can materially change underwriting outcomes even when the underlying cardiac condition has not changed. A cardiac applicant who has brought blood pressure from 150/95 to 120/78 with consistent medication management is a better underwriting candidate than one with the same cardiac history and inadequately controlled hypertension. Our resource on life insurance for high blood pressure covers how BP control specifically affects cardiac and overall life insurance underwriting, and our resource on life insurance for diabetes covers how diabetes management intersects with cardiac underwriting for applicants dealing with both conditions simultaneously.

Medication Compliance and Medical Management

A consistent, well-documented medication regimen for the cardiac condition and its associated risk factors is a positive underwriting signal. It demonstrates both that the treating physicians have a management plan in place and that the patient is following it — the combination of active medical management and patient compliance that produces the controlled profiles underwriters want to see. Gaps in medication fill history, frequent medication changes driven by uncontrolled symptoms rather than clinical optimization, or records that suggest the applicant is not regularly following up with their cardiologist all introduce uncertainty that tends to push underwriting outcomes in a more conservative direction. Sleep apnea, when present, adds another layer: untreated sleep apnea significantly elevates cardiac risk, while consistent documented CPAP compliance removes that concern from the underwriting picture.

What Typically Improves Heart Disease Life Insurance Offers

The difference between an offer that is technically possible but priced so high it is not useful and an offer that is genuinely fair is not just carrier selection — it is the combination of carrier selection, timing, and how the application is prepared. The applicants who receive the best outcomes within their specific cardiac profile share several patterns that are worth understanding before you start the application process.

A clean stability window — a defined period during which nothing has worsened, no new events have occurred, testing has been consistent, and routine cardiology follow-ups have documented stability — is the single most powerful positive factor in cardiac underwriting. This does not mean perfect cardiac health or a return to pre-disease baseline. It means a clear and documented track record of “managed, stable, no progression.” Carriers become meaningfully more flexible when they can see that stability clearly in the records, and that flexibility translates directly into better rate classes and lower premiums.

Updated cardiac testing that reflects the current status of the condition is the second most impactful factor. An application submitted with a two-year-old echocardiogram and no recent cardiology notes forces the underwriter to estimate current status rather than confirm it — and conservative estimates are worse than accurate documentation. When we work with cardiac applicants, we prefer recent cardiology notes and testing that clearly document stability in plain language. If the most recent testing is outdated, sometimes the most productive first step before applying is getting current follow-up care so the application can be supported by documentation that actually reflects today’s condition.

Risk factor control, as discussed above, is one of the most underestimated levers in cardiac underwriting. Controlled blood pressure and cholesterol often influence the final rate class as much as the cardiac diagnosis itself. For some applicants, addressing the risk factor picture — whether through better medication management, weight loss, or consistent CPAP compliance if sleep apnea is present — can change underwriting outcomes even when the underlying heart disease history has not changed. Our resource on life insurance table ratings explained covers how all of these factors combine into the table rating system that most carriers use for cardiac and other impaired-risk underwriting, and what moving from one table to the next actually means in premium terms.

Understanding Table Ratings for Heart Disease

Most people applying for life insurance receive either a preferred rate, a standard rate, or a rated offer. For cardiac applicants, rated offers — also called table-rated or substandard offers — are the most common outcome for conditions with any meaningful history beyond mild and fully resolved cases. Understanding how table ratings work prevents the common mistake of dismissing an offer that is actually appropriate and competitive within the context of the specific cardiac history.

Table ratings are typically expressed as Table 2 through Table 16 (or occasionally higher), with each table representing an additional 25 percent above the standard rate. A Table 4 rating means the applicant is paying 100 percent above standard rate for that policy — effectively double the base price. A Table 8 means triple the standard rate. Carriers differ in how they structure table ratings and how many tables they use, but this 25-percent-per-table framework is the most common approach in the industry. For cardiac applicants, the table assigned reflects the carrier’s overall assessment of excess mortality risk given the specific diagnosis and the current stability profile. A Table 4 offer from a carrier that evaluated the full cardiac picture accurately is often a better outcome than a standard offer from a carrier that did not fully review the condition — the price may look higher in the moment but the coverage is real, appropriately underwritten, and provides the protection the household needs.

For applicants who receive a rated offer and believe the rating is higher than the medical evidence supports, there is a process for requesting reconsideration with additional documentation. Our underwriting team at Diversified Insurance Brokers reviews table-rated offers against the market regularly to determine whether a different carrier would arrive at a lower table for the same medical profile — this is one of the concrete ways that working with an independent multi-carrier broker produces better outcomes than accepting the first offer from a single company.

Term vs. Permanent Life Insurance With Heart Disease

The question of term versus permanent life insurance is an important one for cardiac applicants, and the answer depends on the intersection of the coverage purpose, the available budget at the underwritten rate, and long-term planning goals. Both policy types are available for many cardiac applicants — the cardiac history does not limit the policy type in most cases, though it does affect the premium for any policy.

Term life insurance is almost always the first option to evaluate for cardiac applicants whose primary goal is income replacement, debt protection, or financial protection during peak earning and obligation years. It provides the largest death benefit for the lowest premium, which matters particularly for cardiac applicants who may already be dealing with higher-than-standard pricing due to the medical history. A term policy appropriately sized for the household’s actual financial needs — which our resource on how much life insurance you need covers in detail — and priced at whatever table rating the cardiac profile produces is often far more meaningful coverage than a small permanent policy that fits within a tighter budget constraint. Understanding how term life insurance works is the starting point for evaluating whether term meets the primary protection need before considering permanent alternatives.

Permanent life insurance — whether whole life or guaranteed universal life — is relevant when the coverage purpose includes lifelong protection rather than a time-bounded need. For cardiac applicants concerned about future insurability — a legitimate concern given that cardiac conditions can progress and make future coverage more expensive or unavailable — securing permanent coverage now at the current rating establishes a lifelong death benefit that cannot be taken away by future health changes. The conversion privilege in term policies is also worth understanding in this context: many term policies allow conversion to permanent coverage without new medical underwriting, which means a cardiac applicant can secure a large term policy now and later convert a portion to permanent without the cardiac history creating a new underwriting event. Our resource on permanent life insurance covers the structures available, and our resource on converting term to permanent covers how this option works and why it is particularly valuable for applicants with medical histories that may worsen over time.

Cardiac Conditions With Additional Complexity

Several cardiac conditions and co-existing conditions create underwriting complexity beyond what the standard cardiac underwriting framework addresses, and being clear about these situations helps applicants understand why additional care in carrier selection and case preparation is warranted.

Heart disease combined with diabetes is one of the most common co-morbidity combinations in life insurance underwriting, and it changes the risk picture meaningfully. When both conditions are well-controlled — A1C consistently in a good range, cardiac follow-up stable, no complications affecting kidneys or peripheral circulation — the combined profile is manageable for experienced underwriters. When either condition is inadequately controlled, the risk picture becomes more complex and more conservative carrier responses are common. Our resource on life insurance for diabetes covers how diabetes control specifically interacts with carrier underwriting guidelines.

Bundle branch block — a conduction delay in the heart’s electrical system that is sometimes found incidentally and sometimes associated with structural heart disease — is evaluated differently depending on whether it is right bundle branch block (RBBB) or left bundle branch block (LBBB), and whether there is underlying structural disease. Our resource on life insurance for bundle branch block covers the specific underwriting considerations for this condition. Stroke history in a cardiac applicant — particularly when the stroke is related to atrial fibrillation or other cardiac sources — creates an additional underwriting layer that our resource on life insurance for stroke covers in detail. For the most complex cardiac histories — including heart transplant recipients — our resource on life insurance for heart transplants covers the specific underwriting framework and the narrower but real market of carriers who evaluate these cases.

What to Do if You Have Been Declined Before

A prior decline for life insurance due to heart disease does not permanently close the door to coverage, but it does require deliberate strategy in how subsequent applications are approached. Declines from prior carriers must be disclosed on new applications, and multiple declines in a short period can themselves create underwriting concern — which is why the first principle after a prior decline is to be very deliberate about the next application rather than submitting widely and hoping for a different result.

The most productive approach after a prior decline is to work with a broker who can pre-screen your specific cardiac profile across multiple carriers informally before any formal application is submitted. This pre-screening process — sharing the key clinical details with underwriting contacts at multiple companies and getting an indication of likely outcomes before anything is official — allows the best available carrier to be identified and the application to go to that company first, in the best possible form. It also identifies whether any changes in timing or documentation could improve the likely outcome before applying. Our team at Diversified Insurance Brokers manages this process regularly for cardiac applicants with prior declines, and the outcome is frequently more positive than the initial decline would suggest when the right carrier and right preparation are combined. The broader strategy for handling prior declines is similar to how we approach complex multi-condition underwriting — described in our resource on why to work with an independent life insurance broker.